Literature DB >> 8697454

Proton magnetic resonance spectroscopic imaging of pediatric low-grade astrocytomas.

J A Lazareff1, C Olmstead, K H Bockhorst, J R Alger.   

Abstract

Despite their uniform histologic appearance, pediatric low-grade astrocytomas (LGA) often exhibit a rather unpredictable clinical course. It is presently unclear whether certain specific genetic, immunologic and/or metabolic features underlie these observed variations. In order to address this question we examined the tumor distribution of choline compounds (Cho), creatine (Cr) and N-acetyl aspartate (NAA) in seven children with midline LGA by means of proton magnetic resonance spectroscopy imaging (H-MRSI). Studies were performed with a 1.5 T GE Signa Scanner equipped with the standard head coil; nominal voxel size was 7.5 x 7.5 x 15 mm. This spatial resolution allowed us to select and independently evaluate multiple regions of interest (ROI) in the tumor as well as in areas of normal brain from the same individual. Normalized values of the observed signal intensities demonstrated a lower NAA and Cr content in the tumors than in the surrounding normal brain. Intratumoral Cho signals were also below normal values in all but one patient. The average Cho:NAA ratio was consistently higher in the tumor than in the normal brain. However, there was a wide variation (up to fourfold) in the Cho:NAA ratios of different ROIs, even within the same tumor. Our results clearly indicate that pediatric LGAs are metabolically heterogeneous, a feature that may be relevant to the understanding of their variable biologic behavior. Inasmuch as unique metabolic patterns were observed in some LGAs, we believe that systematic HMRSI studies of these patients may help define subsets within the group with specific therapeutic requirements.

Entities:  

Mesh:

Year:  1996        PMID: 8697454     DOI: 10.1007/bf00266813

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  15 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

2.  Human brain tumors: spectral patterns detected with localized H-1 MR spectroscopy.

Authors:  H Kugel; W Heindel; R I Ernestus; J Bunke; R du Mesnil; G Friedmann
Journal:  Radiology       Date:  1992-06       Impact factor: 11.105

3.  N-acetyl-L-aspartic acid content of human neural tumours and bovine peripheral nervous tissues.

Authors:  J V Nadler; J R Cooper
Journal:  J Neurochem       Date:  1972-02       Impact factor: 5.372

Review 4.  Nuclear magnetic resonance spectroscopy studies of the brain.

Authors:  R A Kauppinen; S R Williams
Journal:  Prog Neurobiol       Date:  1994-09       Impact factor: 11.685

5.  Proton MR spectroscopy of intracranial tumours: in vivo and in vitro studies.

Authors:  S S Gill; D G Thomas; N Van Bruggen; D G Gadian; C J Peden; J D Bell; I J Cox; D K Menon; R A Iles; D J Bryant
Journal:  J Comput Assist Tomogr       Date:  1990 Jul-Aug       Impact factor: 1.826

6.  Localized 1H NMR spectroscopy in fifty cases of newly diagnosed intracranial tumors.

Authors:  P Demaerel; K Johannik; P Van Hecke; C Van Ongeval; S Verellen; G Marchal; G Wilms; C Plets; J Goffin; F Van Calenbergh
Journal:  J Comput Assist Tomogr       Date:  1991 Jan-Feb       Impact factor: 1.826

7.  Low-grade astrocytomas may arise from different astrocyte lineages.

Authors:  J M Piepmeier; I Fried; R Makuch
Journal:  Neurosurgery       Date:  1993-10       Impact factor: 4.654

8.  Multimodality correlative study of canine brain tumors. Proton magnetic resonance spectroscopy, positron emission tomography, and histology.

Authors:  J H Anderson; J D Strandberg; D F Wong; P S Conti; P B Barker; S J Blackband; J Hilton; T K Natarajan; R F Dannals; M A Samphilipo
Journal:  Invest Radiol       Date:  1994-06       Impact factor: 6.016

Review 9.  A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline.

Authors:  B L Miller
Journal:  NMR Biomed       Date:  1991-04       Impact factor: 4.044

10.  Development of anaplastic changes in low-grade astrocytomas of childhood.

Authors:  P B Dirks; V Jay; L E Becker; J M Drake; R P Humphreys; H J Hoffman; J T Rutka
Journal:  Neurosurgery       Date:  1994-01       Impact factor: 4.654

View more
  7 in total

1.  Variation of post-treatment H-MRSI choline intensity in pediatric gliomas.

Authors:  J A Lazareff; R K Gupta; J Alger
Journal:  J Neurooncol       Date:  1999-02       Impact factor: 4.130

2.  Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma.

Authors:  R K Gupta; T F Cloughesy; U Sinha; J Garakian; J Lazareff; G Rubino; L Rubino; D P Becker; H V Vinters; J R Alger
Journal:  J Neurooncol       Date:  2000-12       Impact factor: 4.130

Review 3.  Proton MR Spectroscopy of Pediatric Brain Disorders.

Authors:  Stefan Blüml; Alexander Saunders; Benita Tamrazi
Journal:  Diagnostics (Basel)       Date:  2022-06-14

4.  The correlation between 1H MRS choline concentrations and MR diffusion trace values in human brain tumors.

Authors:  Dita Wagnerova; Filip Jiru; Monika Dezortova; Lydie Vargova; Eva Sykova; Milan Hajek
Journal:  MAGMA       Date:  2008-10-25       Impact factor: 2.310

5.  Proton magnetic resonance spectroscopic imaging in pediatric pilomyxoid astrocytoma.

Authors:  Bayram Cirak; Alena Horská; Peter B Barker; Peter C Burger; Benjamin S Carson; Anthony M Avellino
Journal:  Childs Nerv Syst       Date:  2004-09-11       Impact factor: 1.475

6.  Quantitative short echo time 1H-MR spectroscopy of untreated pediatric brain tumors: preoperative diagnosis and characterization.

Authors:  A Panigrahy; M D Krieger; I Gonzalez-Gomez; X Liu; J G McComb; J L Finlay; M D Nelson; F H Gilles; S Blüml
Journal:  AJNR Am J Neuroradiol       Date:  2006-03       Impact factor: 3.825

7.  Comparison of perfusion, diffusion, and MR spectroscopy between low-grade enhancing pilocytic astrocytomas and high-grade astrocytomas.

Authors:  M de Fatima Vasco Aragao; M Law; D Batista de Almeida; G Fatterpekar; B Delman; A S Bader; M Pelaez; M Fowkes; R Vieira de Mello; M Moraes Valenca
Journal:  AJNR Am J Neuroradiol       Date:  2014-04-03       Impact factor: 3.825

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.